Tara Daniel
May 18, 2012
Stage 1 Meaningful Use
Data Capture and Sharing
Advanced Clinical Processes
Improved Outcomes
Overview of Meaningful Use
Measure Insight
Attestation Process
MU Overview Attestation ProcessMeasure Insight
Objectives
MU Overview Attestation ProcessMeasure Insight
Overview
Long-term Initiative
Changes Over Time
Central to Health Information Technology
Timeline2009
HITECH Act
June 2010ONC Final Rule
for EHR Certification
January 2011TennCare acceptsAIU attestations
July 2010CMS Final Rule for Incentive Program
April 2012TennCare acceptsMU attestations
2021Program End
2016Last Year
to Begin Program
MU Overview Attestation ProcessMeasure Insight
Meaningful Use Improve Quality, Safety, Efficiency, and Reduce Health Disparities
Improve Population and Public Health
Engage Patients and Families in their Healthcare Improve Care Coordination
Maintain Privacy and Security
Data Capture and Sharing
Advanced Clinical Processes
Improved Outcomes
MU Overview Attestation ProcessMeasure Insight
Facilitate Successful Attestation
Evaluate Attestations
Promote Participation
Collect and Analyze Data
Facilitate Successful Attestation
Evaluate Attestations
Quality Oversight Role
informedresponsible
relevant
MU Overview Attestation ProcessMeasure Insight
Meaningful Use Process
MU Overview Attestation ProcessMeasure Insight
Incentive Payments
1
5
4
3
2
6
Payment Year
AIU
Stage 2 MU
Stage 2 MU
Stage 1 MU
Stage 1 MU
Stage 3 MU
$21,250
$8,500
$8,500
$8,500
$8,500
$8,500
Program Requirements Payment
$63,750
2014
MU Overview Attestation ProcessMeasure Insight
Meaningful Use Process
Meaningful Use
Prepared
Performed
Attested
Verified
PaidAudited
Data Compiled, Published
TennCare Processes
EP/EH Processes
MU Overview Attestation ProcessMeasure Insight
Clarify and Affirm Meaningful Use Criteria
Aid in the Attestation Process
Address Specific Questions and Concerns
TennCare as a Resource
MU Overview Attestation ProcessMeasure Insight
Medicaid EHR Incentive Program
Eligible Professionals (EPs)
Meaningful Use
Scope and Applicability
MU Overview Attestation ProcessMeasure Insight
Measure Insight
Types of Measures
Measure Parameters
Measure Concerns
EPsConsultants (Optional)
Vendors
Prepared
Performed
Attested
MU Overview Attestation ProcessMeasure Insight
15 Core Measures
5 of 10 Menu Measures
6-9 Clinical Quality Measures
Stage 1 Meaningful Use
MU Overview Attestation ProcessMeasure Insight
Calculated Percentage
Types of Measures
Measure at a GlanceType: calculated percentageDenominator: unique patientsDuration: calculated over the entire EHR reporting period
Problem Lists3
More than 80 percent of all unique patients seen by the EP have at least one entry or an indication that no problems are known for the patient as structured data.
numerator
denominator
MU Overview Attestation ProcessMeasure Insight
Calculated Percentage
Types of Measures
Patient Lists3
Generate at least one report listing patients of the EP with a specific condition.
Measure at a GlanceType: task to be performedDenominator: noneDuration: completed during the EHR reporting period
Task to be PerformedYes
No
MU Overview Attestation ProcessMeasure Insight
Types of Measures
The EP has enabled this functionality and has access to at least one internal or external formulary for the entire EHR reporting period.
Measure at a GlanceType: enabled functionDenominator: noneDuration: enabled during the entire EHR reporting period
Drug Formulary Checks
1
Enabled FunctionYes
No
MU Overview Attestation ProcessMeasure Insight
Measure Categories
MU Overview Attestation ProcessMeasure Insight
Unique Patients
MU Overview Attestation ProcessMeasure Insight
More than 50 percent of all unique patients seen by the EP have demographics recorded as structured data.
More than 80 percent of all unique patients seen by the EP have at least one entry or an indication that no problems are known for the patient as structured data.
More than 80 percent of all unique patients seen by the EP have at least one entry (or an indication that the patient is not currently prescribed any medication) recorded as structured data.
More than 80 percent of all unique patients seen by the EP have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data.
Measure at a GlanceType: calculated percentageDenominator: unique patients with a medication list, which may be limited to patients maintained by CEHRTDuration: calculated over the entire EHR reporting period
More than 30 percent of all unique patients with at least one medication in their medication list seen by the EP have at least one medication order entered using CPOE.
MU Overview Attestation ProcessMeasure Insight
Based on Subset
MU Overview Attestation ProcessMeasure Insight
Core Measure 12
More than 50 percent of all patients who request an electronic copy of their health information are provided it within 3 business days.
Electronic Copies12 Measure at a GlanceType: calculated percentageDenominator: unique patients requesting copies at least four days prior to the end of the reporting period, may be limited to patients maintained by CEHRTDuration: calculated over the entire EHR reporting period
MU Overview Attestation ProcessMeasure Insight
Menu Measure 5
Measure at a GlanceType: calculated percentageDenominator: unique patientsDuration: calculated over the entire EHR reporting period
Patient Electronic Access
5At least 10 percent of all unique patients seen by the EP are provided timely (available to the patients within four business days of being updated in the certified EHR technology) electronic access to their health information subject to the EP's discretion to withhold certain information.
MU Overview Attestation ProcessMeasure Insight
Core Measure 13
Clinical summaries provided to patients for more than 50 percent of all office visits within 3 business days.
Measure at a GlanceType: calculated percentageDenominator: office visitsDuration: calculated over the entire EHR reporting period
Clinical Summaries13
MU Overview Attestation ProcessMeasure Insight
Core Measure 14
Performed at least one test of certified EHR technology’s capacity to electronically exchange key clinical information.
Exchange Information
14 Measure at a GlanceType: task to be performedDenominator: noneDuration: completed any time during the reporting period’s year, so long that the date is on or before the last day of the reporting period
Attestation Process
MU Overview Attestation ProcessMeasure Insight
Navigating to the Portal
MU Overview Attestation ProcessMeasure Insight
Attestation Process
MU Overview Attestation ProcessMeasure Insight
http://pipp.tenncare.tn.gov
AIU
General Questions
MU Overview Attestation ProcessMeasure Insight
EHR Reporting Period
Provider Specialty
Number of Unique Patients in EHR
County of Practice
Core & Menu Measures
MU Overview Attestation ProcessMeasure Insight
2
3
Core & Menu Measures
MU Overview Attestation ProcessMeasure Insight
Patient Lists3
Generate at least one report listing patients of the EP with a specific condition.
Measure at a GlanceType: task to be performedDenominator: noneDuration: completed during the EHR reporting period
Core & Menu Measures
MU Overview Attestation ProcessMeasure Insight
Implement one clinical decision support rule.
Measure at a GlanceType: enabled functionDenominator: noneDuration: enabled during the entire reporting period
Clinical Decision Support
11
More than 40 percent of all permissible prescriptions written by the EP are transmitted electronically using certified EHR technology.
Measure at a GlanceType: calculated percentageDenominator: permissible prescriptionsDuration: calculated over the entire EHR reporting period
eRx4
Core & Menu Measures
MU Overview Attestation ProcessMeasure Insight
Performed at least one test of CEHRT’s capacity to submit electronic data to immuniza-tion registries and follow up submissions if the test is successful (unless none of the immunization registries to which the EP submits such information has the capacity to receive the information electronically)
Measure at a GlanceType: task to be performedDenominator: noneDuration: completed any time during the reporting period’s year, so long that the date is on or before the last day of the reporting period
Immunization Registry9
Clinical Quality Measures
MU Overview Attestation ProcessMeasure Insight
Attest to the 3 Core CQMs
Automatically Instruct How Many Alternate Core (0-3)
Select 3 Additional CQMs
Attestation Tips
MU Overview Attestation ProcessMeasure Insight
Review Measures Before Attesting
Save and Exit to Return Later
Be Thorough
Proofread
Be Early
TennCare Resources
MU Overview Attestation ProcessMeasure Insight
Attestation Webinar: May 23, 2012: 9:00 AM, Recorded
TennCare Website: http://tn.gov/tenncare/mu.shtml
E-mail Address: [email protected]